Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Zoulim

Showing results (81-90 of 499) with videos related to

Pageof 50
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
HBV 2021: New therapeutic strategies against an old foeArmando Andres Roca Suarez, Barbara Testoni, Fabien Zoulim
Hepatology (Baltimore, Md.)|April 1, 2025
Getting to HBV Cure - will new biomarkers help?Jordan J Feld, Adam J Gehring, Fabien Zoulim
Current Opinion in Virology|May 20, 2018
Perspectives and limitations for nucleo(t)side analogs in future HBV therapiesMassimo Levrero, Miroslava Subic, Francois Villeret, et al.
Journal of Hepatology|February 9, 2012
Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutantsGaëtan Billioud, Christian Pichoud, Romain Parent, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2023
New Perspectives on Development of Curative Strategies for Chronic Hepatitis BJordan J Feld, Anna S Lok, Fabien Zoulim
Vaccines|February 26, 2026
Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy GapsEnkhtuul Batbold, Naranjargal Dashdorj, Fabien Zoulim, et al.
Expert Review of Gastroenterology & Hepatology|February 9, 2010
End points of therapy in chronic hepatitis BSi Nafa Si Ahmed, Marie Ecochard, Fabien Zoulim
Antiviral Research|August 16, 2015
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesNathalie Isorce, Julie Lucifora, Fabien Zoulim, et al.
Gastroenterology|April 29, 2014
Strategies to inhibit entry of HBV and HDV into hepatocytesStephan Urban, Ralf Bartenschlager, Ralf Kubitz, et al.
Journal of Hepatology|May 22, 2014
Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral HepatitisTobias Boettler, Darius Moradpour, Robert Thimme, et al.
Pageof 50

Showing results (81-90 of 499) with videos related to

Sort By:
Pageof 50
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
HBV 2021: New therapeutic strategies against an old foeArmando Andres Roca Suarez, Barbara Testoni, Fabien Zoulim
Hepatology (Baltimore, Md.)|April 1, 2025
Getting to HBV Cure - will new biomarkers help?Jordan J Feld, Adam J Gehring, Fabien Zoulim
Current Opinion in Virology|May 20, 2018
Perspectives and limitations for nucleo(t)side analogs in future HBV therapiesMassimo Levrero, Miroslava Subic, Francois Villeret, et al.
Journal of Hepatology|February 9, 2012
Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutantsGaëtan Billioud, Christian Pichoud, Romain Parent, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2023
New Perspectives on Development of Curative Strategies for Chronic Hepatitis BJordan J Feld, Anna S Lok, Fabien Zoulim
Vaccines|February 26, 2026
Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy GapsEnkhtuul Batbold, Naranjargal Dashdorj, Fabien Zoulim, et al.
Expert Review of Gastroenterology & Hepatology|February 9, 2010
End points of therapy in chronic hepatitis BSi Nafa Si Ahmed, Marie Ecochard, Fabien Zoulim
Antiviral Research|August 16, 2015
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesNathalie Isorce, Julie Lucifora, Fabien Zoulim, et al.
Gastroenterology|April 29, 2014
Strategies to inhibit entry of HBV and HDV into hepatocytesStephan Urban, Ralf Bartenschlager, Ralf Kubitz, et al.
Journal of Hepatology|May 22, 2014
Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral HepatitisTobias Boettler, Darius Moradpour, Robert Thimme, et al.
Pageof 50